EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peripherally administered androgen receptor–targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model

Changwoo Lee, Zhigang Yu, Curtis J Kuo, Leon Tejwani, Rosalie M Grijalva, Eunwoo Bae, Hien T Zhao, Janghoo Lim, Andrew P Lieberman

Journal of Clinical Investigation · 03.11.2025 · 135 (21)

DOI: 10.1172/jci182955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 28.08.2025. Verfasst von Changwoo Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interdepartmental Neuroscience Program, Department of Neuroscience, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Receptors, Androgen, Oligonucleotides, Antisense, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Degeneration of the neuromuscular system is a characteristic feature of spinal and bulbar muscular atrophy (SBMA), a CAG/polyglutamine (polyQ) expansion disorder caused by mutation in the androgen receptor (AR). Using a gene-targeted mouse model of SBMA, AR113Q mice, we demonstrate age-dependent degeneration of the neuromuscular system that initially manifests with muscle weakness and atrophy and progresses to include denervation of neuromuscular junctions and lower motor neuron soma atrophy. Using this model, we tested the hypothesis that therapeutic intervention targeting skeletal muscle during this period of disease progression arrests degeneration of the neuromuscular system. To accomplish this, AR -targeted antisense oligonucleotides were administered subcutaneously to symptomatic AR113Q mice to reduce expression of polyQ AR in peripheral tissues but not in the spinal cord. This intervention rescued muscle atrophy, neuromuscular junction innervation, lower motor neuron soma size, and survival in aged AR113Q mice. Single-nucleus RNA sequencing revealed age-dependent transcriptional changes in the AR113Q spinal cord during disease progression, which were mitigated by peripheral AR gene silencing. Our findings underscore the intricate interplay between peripheral tissues and the central nervous system in SBMA and emphasize the therapeutic effectiveness of peripheral gene knockdown in symptomatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenOligonucleotides, AntisenseMuscular Atrophy, SpinalAnimalsMiceDisease Models, AnimalMotor NeuronsSpinal CordMaleMuscle, SkeletalNeuromuscular JunctionMice, TransgenicPeptides

Stichwörter der Autor:innen

NeurodegenerationNeuromuscular diseaseNeuroscienceTherapeutics

Substanzen

Receptors, AndrogenOligonucleotides, AntisenseAR protein, mousepolyglutaminePeptides

Autor:innen und Institutionen

  • Interdepartmental Neuroscience Program, Department of Neuroscience, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Pathology and.
  • Cellular and Molecular Biology Graduate Program, Medical Scientist Training Program, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
  • Ionis Pharmaceuticals Inc., Carlsbad, California, USA.
  • Department of Neuroscience, Yale School of Medicine, New Haven, Connecticut, USA.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • NIGMS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging
  • National Institute of General Medical Sciences

Zitieren

APA

Lee, C., Yu, Z., Kuo, C. J., Tejwani, L., Grijalva, R. M., Bae, E., Zhao, H. T., Lim, J., & Lieberman, A. P. (2025). Peripherally administered androgen receptor–targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model. Journal of Clinical Investigation, 135(21). https://doi.org/10.1172/jci182955

Vancouver

Lee C, Yu Z, Kuo CJ, Tejwani L, Grijalva RM, Bae E, et al. Peripherally administered androgen receptor–targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model. Journal of Clinical Investigation. 2025;135(21). doi:10.1172/jci182955

BibTeX
@article{Lee2025,
  author = {Lee, Changwoo and Yu, Zhigang and Kuo, Curtis J and Tejwani, Leon and Grijalva, Rosalie M and Bae, Eunwoo and Zhao, Hien T and Lim, Janghoo and Lieberman, Andrew P},
  title = {Peripherally administered androgen receptor–targeted antisense oligonucleotide rescues spinal pathology in a murine SBMA model},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {21},
  doi = {10.1172/jci182955}
}
Kostenlos starten →